Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2022 Earnings Call Transcript

Operator: Welcome to Adaptimmune and TCR2 joint webcast to discuss their strategic combination announced earlier this morning.

Related Keywords

United Kingdom ,Marc Frahm ,Juli Miller ,Garry Menzel ,Adrian Rawcliffe ,Fernie Rodriguez ,Adaptimmune Therapeutics Plc ,Corporate Affairs At Adaptimmune ,Nasdaq ,Adaptimmune Therapeutics ,Call Transcript March ,Investor Relations ,Corporate Affairs ,Chief Executive Officer ,Growth Penny Stocks ,Buy For ,